Rathi recommends booking profit in Lupin at current valuations. He has a neutral rating and a ‘hold‘ on the Sun Pharma stock because there are several triggers which can drive the earning surprise positively
first published: Jul 23, 2013 02:52 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

